GR861837B - Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them - Google Patents

Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them

Info

Publication number
GR861837B
GR861837B GR861837A GR860101837A GR861837B GR 861837 B GR861837 B GR 861837B GR 861837 A GR861837 A GR 861837A GR 860101837 A GR860101837 A GR 860101837A GR 861837 B GR861837 B GR 861837B
Authority
GR
Greece
Prior art keywords
usage
preparing
novel polypeptide
anticoagulant activity
means containing
Prior art date
Application number
GR861837A
Other languages
English (en)
Inventor
Kramer Prof Dr Martin
Tripier Dr Dominique
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853525428 external-priority patent/DE3525428A1/de
Priority claimed from DE19863601032 external-priority patent/DE3601032A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR861837B publication Critical patent/GR861837B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/141—Feedstock
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR861837A 1985-07-17 1986-07-15 Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them GR861837B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853525428 DE3525428A1 (de) 1985-07-17 1985-07-17 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE19863601032 DE3601032A1 (de) 1986-01-16 1986-01-16 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (1)

Publication Number Publication Date
GR861837B true GR861837B (en) 1986-11-11

Family

ID=25834067

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861837A GR861837B (en) 1985-07-17 1986-07-15 Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them

Country Status (16)

Country Link
US (1) US4791100A (el)
EP (1) EP0209061B1 (el)
JP (1) JPH0764875B2 (el)
KR (1) KR940000758B1 (el)
AU (1) AU593820B2 (el)
CA (1) CA1340102C (el)
DE (1) DE3689525D1 (el)
DK (1) DK173509B1 (el)
ES (1) ES2000216A6 (el)
FI (1) FI862950A7 (el)
GR (1) GR861837B (el)
HU (1) HUT41418A (el)
IE (1) IE61569B1 (el)
IL (1) IL79424A (el)
NO (1) NO862876L (el)
PT (1) PT82993B (el)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE58903988D1 (de) * 1985-04-11 1993-05-13 Hoechst Ag Hirudin-derivat.
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
EP0416035B1 (en) * 1988-05-27 1994-12-07 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
IL87004A (en) * 1988-07-06 1992-08-18 Technion Res & Dev Foundation Method and apparatus for bioaffinity separation
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
ZA907743B (en) * 1989-10-03 1991-07-31 Merrell Dow Pharma Radiolabeled anticoagulant peptides
US5190919A (en) * 1989-11-13 1993-03-02 Board Of Regents, The University Of Texas System Antihemostatic factor vii peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
JPH07504152A (ja) * 1990-02-08 1995-05-11 マゲイニン　ファーマスーティカルズ，　インコーポレーテッド 生物活性ペプチドおよび標的細胞、ウイルス、あるいはウイルス感染細胞の成長を抑制する方法
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
JPH05507273A (ja) * 1990-05-14 1993-10-21 マゲイニン　サイエンセズ　インコーポレーテッド Ｄアミノ酸残基を有する生物活性ペプチドの組成物およびそれによる治療方法
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
EP0559647A1 (en) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
US5428009A (en) * 1990-07-16 1995-06-27 Merck & Co., Inc. Lipopeptide derivatives
CA2047527A1 (en) * 1990-07-24 1992-01-25 Christopher Dunwiddie Method for administering a therapeutic anticoagulant
DE4031731A1 (de) * 1990-10-06 1992-04-09 Basf Ag Protein aus hirudo medicinalis
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US5385884A (en) * 1991-08-27 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
CA2120337A1 (en) * 1991-10-16 1993-04-17 Michael A. Zasloff Composition and treatment with biologically active peptides and antibiotic
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
IL109258A0 (en) * 1993-04-09 1994-07-31 Bio Technology General Corp Production of recombinant factor xa inhibitor of leech hirudo medicinalis
US5863534A (en) * 1993-04-09 1999-01-26 Bio-Technology General Corp. Polypeptide having factor Xa inhibitory method of reducing blood coagulation with a novel polypeptide having factor Xa inhibitory activity
GB9309509D0 (en) * 1993-05-07 1993-06-23 Merck Patent Gmbh Thrombin inhibitors
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) * 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69625623T2 (de) 1996-01-31 2003-11-06 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
US6699836B2 (en) 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
AU4054900A (en) * 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
US20110220575A1 (en) * 2008-11-19 2011-09-15 Nandu Deorkar New chromatographic media based on phenoxy alkyl and alkoxy-or phenoxy-phenyl alkyl ligands
CN102373216B (zh) * 2011-10-28 2013-06-05 元昊 一种含有医用水蛭素基因的重组真核汉逊酵母工程菌株的构建及重组水蛭素的生产工艺
CN113956339B (zh) * 2021-10-28 2023-02-24 中国药科大学 宽体金线蛭抗凝血因子XIa多肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten

Also Published As

Publication number Publication date
NO862876D0 (no) 1986-07-16
JPH0764875B2 (ja) 1995-07-12
IL79424A0 (en) 1986-10-31
AU6023386A (en) 1987-01-22
DE3689525D1 (de) 1994-02-24
IE61569B1 (en) 1994-11-16
KR870001237A (ko) 1987-03-12
KR940000758B1 (ko) 1994-01-29
NO862876L (no) 1987-01-19
EP0209061A3 (en) 1989-03-15
CA1340102C (en) 1998-10-27
EP0209061A2 (de) 1987-01-21
EP0209061B1 (de) 1994-01-12
HUT41418A (en) 1987-04-28
PT82993A (de) 1986-08-01
IL79424A (en) 1992-02-16
AU593820B2 (en) 1990-02-22
DK338486D0 (da) 1986-07-16
DK338486A (da) 1987-01-18
DK173509B1 (da) 2001-01-15
IE861902L (en) 1987-01-17
FI862950A7 (fi) 1987-01-18
FI862950A0 (fi) 1986-07-15
ES2000216A6 (es) 1988-01-16
PT82993B (pt) 1989-01-30
JPS6222799A (ja) 1987-01-30
US4791100A (en) 1988-12-13

Similar Documents

Publication Publication Date Title
ZA875841B (en) Method of culturing leukocytes
EP0225254A3 (en) Specific antibody-containing substance from eggs and method of production and use thereof
EP0193356A3 (en) Method for analysis of subpopulations of blood cells
PL268521A1 (en) The method of manufacture of new polypeptides containing nor-statine and nor-cyclostatine
PL261052A1 (en) Method of obtaining stable variety of thorasemide
PL263078A1 (en) Method of obtaining novel benzamides
PL268313A1 (en) Method of obtaining novel ocylopeptides
BG40573A1 (en) Method for simultaneous preparing of acetoxymethyllongipholene and isolongipholene
RO92738B1 (ro) Metoda de analgezie rapida
PL254237A1 (en) Method of obtaining stable proteinous fraction of human serum
PL252903A1 (en) Method of obtaining novel polypeptides
PL253417A1 (en) Method of obtaining n-2-aminoethyl-3-aminopropylotrimetoxysilane
GB8517627D0 (en) Method of testing
PL256772A1 (en) Method of preparing an ensilage
PL256954A2 (en) Method of obtaining nitropigment preparations
PL141572B2 (en) Method of obtaining nitropigment preparations
BG40410A1 (en) Method for preparing of amicazine
BG46958A1 (en) Method for preparing of dinitronaphthalene
BG40067A1 (en) Method for preparing of n- benzyloxycarbonyl- l- triptophyl- l- serine- hydrazide
BG39870A1 (en) Method for preparing of alpha cyanacrylates
CS823685A1 (en) Method of cis-diaminodichloroplatinum complex preparation
CS622986A2 (en) Method of diamino-platinous complex preparation
IE852430L (en) Method of measuring enzymic activity of chymopapains
IL77162A0 (en) Compositions and method for the modification of insulin activity
PL254154A1 (en) Method of obtaining adsorbents of high activity for paraisomers